While considering the benefits of GLP-1 and GIP/GLP-1 receptor agonist therapy, caution is needed in clinical scenarios for discontinuation of drugs before procedures, as people with type 2 diabetes risk worsening diabetes control. Here, GIP is linked to diabetes mellitus.